A 52-year-old man with a history of smoking and chronic cough presents with hemoptysis. Chest X-ray shows a 3 cm peripheral lung nodule in the right lower lobe. Which is the most appropriate next investigation to characterize this lesion and guide further management?

Explanation

## Investigation of Choice for Characterization of Lung Nodule ### Clinical Context A peripheral lung nodule in a smoker with hemoptysis raises concern for malignancy. The nodule size (3 cm) and location (peripheral) are critical factors in determining the next imaging step. ### Why High-Resolution CT Chest with Contrast? **Key Point:** HRCT is the gold standard for characterizing lung nodules and evaluating the entire lung parenchyma, mediastinum, and pleura. **High-Yield:** HRCT can assess: - Nodule morphology (spiculation, cavitation, ground-glass opacity) - Size and growth rate (serial imaging) - Relationship to adjacent structures - Presence of satellite nodules or pleural involvement - Lymph node involvement ### Role of Other Investigations | Investigation | Indication | Limitation | |---|---|---| | **HRCT with contrast** | First-line for nodule characterization | None for this scenario | | **PET scan** | Metabolic activity assessment; useful for nodules >1 cm with intermediate probability | Not first-line; requires HRCT findings first | | **Bronchoscopy** | Peripheral nodules are difficult to reach; better for central lesions | Low diagnostic yield for peripheral nodules | | **Sputum cytology** | Low sensitivity; rarely used for nodule diagnosis | Outdated approach | ### Clinical Pearl For peripheral nodules >2.5 cm in a high-risk patient (smoker, hemoptysis), HRCT with contrast provides both morphologic detail and staging information. If imaging shows features suspicious for malignancy (spiculation, heterogeneous enhancement), PET-CT or biopsy follows. **Mnemonic: HRCT First for Nodules — Histology, Radiology, Contrast, Tissue** - Histology: morphologic detail - Radiology: comprehensive lung assessment - Contrast: enhancement patterns aid diagnosis - Tissue: biopsy only after imaging characterization ### Next Steps After HRCT If HRCT shows high-risk features → PET-CT for metabolic activity → Consider biopsy (CT-guided or bronchoscopic) based on probability of malignancy.